Cell Host & Microbe
Volume 24, Issue 5, 14 November 2018, Pages 717-730.e5
Journal home page for Cell Host & Microbe

Article
Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection

https://doi.org/10.1016/j.chom.2018.10.012Get rights and content
Under an Elsevier user license
open archive

Highlights

  • Broadly neutralizing antibodies (bNAbs) were isolated from donors who cleared HCV

  • Most autologous HCV strains were sensitive to these bNAbs

  • HCV strains that evolved resistance to these bNAbs lost replicative fitness

  • bNAbs targeting the E2 front layer contributed directly to HCV clearance

Summary

The role that broadly neutralizing antibodies (bNAbs) play in natural clearance of human hepatitis C virus (HCV) infection and the underlying mechanisms remain unknown. Here, we investigate the mechanism by which bNAbs, isolated from two humans who spontaneously cleared HCV infection, contribute to HCV control. Using viral gene sequences amplified from longitudinal plasma of the two subjects, we found that these bNAbs, which target the front layer of the HCV envelope protein E2, neutralized most autologous HCV strains. Acquisition of resistance to bNAbs by some autologous strains was accompanied by progressive loss of E2 protein function, and temporally associated with HCV clearance. These data demonstrate that bNAbs can mediate clearance of human HCV infection by neutralizing infecting strains and driving escaped viruses to an unfit state. These immunopathologic events distinguish HCV from HIV-1 and suggest that development of an HCV vaccine may be achievable.

Keywords

hepatitis C virus
HCV clearance
neutralizing antibodies
binding sites
immunologic memory
antibody specificity

Cited by (0)

10

Lead Contact